Therapeutic modulation of microbiota-host metabolic interactions.
about
Fertility and early pregnancy outcomes after conservative treatment for cervical intraepithelial neoplasiaA Critical Evaluation of Bifidobacterial Adhesion to the Host TissueMicrobial metabolism of dietary components to bioactive metabolites: opportunities for new therapeutic interventionsHUMAN MICROBIOTA. Small molecules from the human microbiotaInflammatory bowel disease as a model for translating the microbiomeStandardizing the experimental conditions for using urine in NMR-based metabolomic studies with a particular focus on diagnostic studies: a reviewFertility and early pregnancy outcomes after treatment for cervical intraepithelial neoplasia: systematic review and meta-analysisGut microbes and the brain: paradigm shift in neuroscience.Resistant starch: promise for improving human healthSelective Spectrum Antibiotic Modulation of the Gut Microbiome in Obesity and Diabetes Rodent Models[Intestinal microbiota and novel therapeutic perspectives for the treatment of metabolic diseases].From in vitro to in vivo Models of Bacterial Biofilm-Related Infections.Metabolomics approaches for characterizing metabolic interactions between host and its commensal microbes.Mechanistic insight into digoxin inactivation by Eggerthella lenta augments our understanding of its pharmacokinetics.Early Gut Microbiota Intervention Suppresses DSS-Induced Inflammatory Responses by Deactivating TLR/NLR Signalling in Pigs.Glycan degradation (GlyDeR) analysis predicts mammalian gut microbiota abundance and host diet-specific adaptationsMetabolic tinkering by the gut microbiome: Implications for brain development and functionThe effects of gut microbiota on CNS function in humans.Bifidobacteria-host interactions--an update on colonisation factors.From promotion to management: the wide impact of bacteria on cancer and its treatmentHonor thy gut symbionts redux.Intestinal dysbiosis associated with systemic lupus erythematosus.The effect of network biology on drug toxicology.Determining microbial products and identifying molecular targets in the human microbiome.Towards a predictive systems-level model of the human microbiome: progress, challenges, and opportunities.The human microbiome is a source of therapeutic drug targets.Characterization and in vitro properties of oral lactobacilli in breastfed infants.Intestinal colonization: how key microbial players become established in this dynamic process: microbial metabolic activities and the interplay between the host and microbes.The microbiome and colorectal neoplasia: environmental modifiers of dysbiosisGut microbiota signatures predict host and microbiota responses to dietary interventions in obese individuals.Protopanaxadiol, an active ginseng metabolite, significantly enhances the effects of fluorouracil on colon cancer.Defective NOD2 peptidoglycan sensing promotes diet-induced inflammation, dysbiosis, and insulin resistance.Intestinal transport and metabolism of bile acidsToward the comprehensive understanding of the gut ecosystem via metabolomics-based integrated omics approach.Insights on the human microbiome and its xenobiotic metabolism: what is known about its effects on human physiology?Cancer and the gut microbiota: an unexpected link.Intestinal microbiota as modulators of the immune systemUnraveling the environmental and genetic interactions in atherosclerosis: Central role of the gut microbiota.Exploring the physiology and pathology of aging in the intestine of Drosophila melanogasterFunctional metagenomic discovery of bacterial effectors in the human microbiome and isolation of commendamide, a GPCR G2A/132 agonist
P2860
Q24186960-B8A56F16-4714-494B-A0BB-0C4ADB76485EQ26740150-FEC4D25A-ED3D-47B9-AD8C-6AE7B015D298Q26751203-6B1AA51D-E9FB-4375-8CFC-F2DBB0A43F88Q26799980-A43EDDBF-C4B6-4E42-9276-F445016A0409Q26853123-1BEA1C66-47E9-4852-BD5D-D39ED42A1224Q28083342-B83F41BE-4BED-40D9-A5CA-1B8841477D0EQ28250529-3BA9D90E-9E33-4650-B533-31D245EDC3C5Q28251501-C0415845-5947-4C10-A425-4D5595BD522FQ28301879-14787321-D58E-4531-9F09-DCE86AFAD68DQ28551809-1F355BC0-0F7E-416C-90BF-840C4FC30D5AQ30353345-D8803863-35D0-44F0-A880-2A45451BDA56Q30424697-C9B1BEE2-A235-4D7F-ACC1-3732A57CE9C8Q30649847-65C9F65B-37DB-45DB-A3DC-675941B7B1CCQ33779249-22F690F4-3ABF-442C-8302-5322B0707C09Q33789614-BFD6F6DC-6A15-4B11-A39F-2E5109AF1C58Q34093458-BE7E00F3-87A3-4429-9D16-20BC1E708F2BQ34129385-02F10202-7B9B-4B90-AE24-D0CEDCA0F05CQ34129414-C72F7674-236C-4A07-97AC-F30FA87803F9Q34256838-1BC6E310-8CC5-4DDE-AE8E-FF6961D80BB6Q34263890-8E935A7C-61B7-4117-9F9C-A774EAF28DF1Q34295129-37C2CB28-4A5B-47D0-8C05-D683CE9DA07DQ34334692-67D05B88-2449-4487-B654-2E274B6B769DQ34363491-B9DC92C1-8203-414F-B47E-0A4EFE02D752Q34625923-23C2E321-EC1F-477C-B108-FD1E29AB6163Q34691436-0752B19D-99CD-43FA-A2A9-A1FABA0DB009Q34726528-CF3B6196-511E-423A-B3C0-B93B7EDF2D2FQ34941255-0266EAC2-50F8-40F7-9D68-95C1BE1F2A70Q34941943-87C9B647-FF4D-4FFC-AA65-D194F2CD1AB1Q34944458-1ECC3510-5093-4F0B-8C54-44A19D0BA38BQ35113086-59385C76-2833-4917-AAC9-1B5887BD023FQ35131299-A5C27FCF-4F99-4CDC-BDC3-75E318366F27Q35192440-DC7A5426-2A62-446D-9666-189FED94290AQ35247159-B4778D9F-E0A0-4AC7-A343-14CC2679F375Q35359043-60E3F87B-A43D-42D2-B399-49B1CFE6ED84Q35492374-4AE19F3E-6A56-4F83-9ACE-E3CFCE42E838Q35546934-0079617E-429E-4089-8495-D9ED77ACCF8FQ35589732-B4AADA1A-7560-4F78-A053-75C7B03ADF26Q35662826-D69170FA-4E22-47D8-9393-27E8AA7E5A23Q35725701-7B9AF20E-14AF-4123-B371-C2D10A56A267Q35748377-4CD958EF-CC31-4565-A3F1-D60767B4B9D5
P2860
Therapeutic modulation of microbiota-host metabolic interactions.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Therapeutic modulation of microbiota-host metabolic interactions.
@en
type
label
Therapeutic modulation of microbiota-host metabolic interactions.
@en
prefLabel
Therapeutic modulation of microbiota-host metabolic interactions.
@en
P2093
P2860
P50
P1476
Therapeutic modulation of microbiota-host metabolic interactions
@en
P2093
Elaine Holmes
Glenn R Gibson
Remy Burcelin
Sven Pettersson
P2860
P304
P356
10.1126/SCITRANSLMED.3004244
P407
P577
2012-06-01T00:00:00Z